Abbas Dehghan MD PhD FESCis a medical doctor and an epidemiologist. He studied Epidemiology at Netherlands Institute for Health Sciences (NIHES) and worked with the Rotterdam Study at the department of epidemiology, Erasmus Medical Center, the Netherlands for more than 10 years. In 2016, he joined the Department of Epidemiology and Biostatistics at Imperial College London as a reader in cardiometabolic disorders.
Dr Dehghan is a member of the steering committee of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium and has led or been involved in many genome-wide association (GWAS) studies. He has been co-PI of COMBI-BIO, an FP7 EU funded project on the metabolomics of atherosclerosis.
Dr Dehghan is working on the genetics of omics, in particular metabolomics, and applying Mendelian Randomisation approach to investigate causal determinants of complex traits and diseases including cardiometabolic disorders, dementia and cancers.
Since January 2020, Dr Dehghan is the director of postgraduate research at the school of public health.
et al., 2022, Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals, Communications Biology, Vol:5
et al., 2022, DNA methylation signature of chronic low-grade inflammation and its role in cardio-respiratory diseases, Nature Communications, Vol:13, ISSN:2041-1723
et al., 2022, Genetic analysis of over half a million people characterises C-reactive protein loci, Nature Communications, Vol:13, ISSN:2041-1723
et al., 2022, Genetic and clinical determinants of abdominal aortic diameter: genome-wide association studies, exome array data and Mendelian randomization study., Human Molecular Genetics, ISSN:0964-6906
et al., 2022, Epicardial fat volume and the risk of cardiometabolic diseases among women and men from the general population, European Journal of Preventive Cardiology, Vol:28, ISSN:2047-4873, Pages:E14-E16